Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Launched on 06/23/2005, the Invesco Biotechnology & Genome ETF (PBE) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

Zacks Investment Research • Dec 3, 2025

Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?

The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.

Zacks Investment Research • Dec 1, 2025

2 ETFs to Watch for Outsized Volume on Biotechnology Stocks

Biotech ETFs PBE and FBT saw trading volumes soar to over four times their averages, signaling rising interest amid a down day for major indexes.

Zacks Investment Research • Nov 18, 2025

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

Seeking Alpha • Nov 11, 2025

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

Seeking Alpha • May 30, 2025

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Seeking Alpha • Feb 25, 2025

PBE: Biotech Could Be Next Big Winner

Biotechnology and genomics sector has not performed well in recent years, making it an attractive investment opportunity. The Invesco Biotechnology & Genome ETF offers comprehensive exposure to the biotech sector with a diversified portfolio. PBE has performed better than some similar ETFs but worse than others, highlighting the importance of stock selection in this sector.

Seeking Alpha • Apr 1, 2024

3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential

Biotech stocks, namely those involved with gene editing, have been explosive.  Just look at CRISPR Therapeutics (NASADQ: CRSP ), for example.

InvestorPlace • Feb 19, 2024

Where Are Biotech ETFs Headed After Q4 Earnings?

Look into how Biotech ETFs performed after Q4 earnings.

Zacks Investment Research • Feb 14, 2024

An ETF Nerd's Exchange Conference Preview

The long-awaited spot bitcoin ETFs are trading after a decade of waiting. So now the ETF and advisor community has some available brain capacity to look forward.

ETF Trends • Jan 16, 2024